Lack of Association of the Ala 45Thr Polymorphism and Other Common Variants of the NeuroD Gene with Type 1 Diabetes

Diabetes

Volumn 53, Issue 4, 2004, Pages 1158-1161

  Vella, Adrian ^a   Howson, Joanna M M ^a   Barratt, Bryan J ^a   Twells, Rebecca C J ^a   Rance, Helen E ^a   Nutland, Sarah ^a   Tuomilehto Wolf, Eva ^b   Tuomilehto, Jaakko ^b   Undlien, Dag E ^c   Rønningen, Kjersti S ^d   Guja, Cristian ^e   Ionescu Tîrgovişte, Constantin ^e   Savage, David A ^f   Todd, John A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e National Institute of Diabetes   (Romania)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; THREONINE;

ADOLESCENT; ADULT; ALLELE; APOPTOSIS; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; NEUROD GENE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 12144290500     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.4.1158     Document Type: Article

References (25)

1. Fajans. SS, Bell GI, Polonsky KS: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971-980, 2001
2. Madsen OD, Jensen J, Petersen HV, Pedersen EE, Oster A, Andersen FG, Jorgensen MC, Jensen PB, Larsson LI, Serup P: Transcription factors contributing to the pancreatic beta-cell phenotype. Horm Metab Res 29:265-270, 1997
3. Kristinsson SY, Thorolfsdottir ET, Talseth B, Steingrimsson E, Thorsson AV, Helgason T, Hreidarsson AB, Arngrimsson R: MODY in Iceland is associated with mutations in HNF-lalpha and a novel mutation in NeuroD1. Diabetologia 44:2098-2103, 2001
4. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 11:2323-2334, 1997
5. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS: Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323-328, 1999
6. Mutoh H, Naya FJ, Tsai MJ, Leiter AB: The basic helix-loop-helix protein BETA2 interacts with p300 to coordinate differentiation of secretin-expressing enteroendocrine cells. Genes Dev 12:820-830, 1998
7. Kennedy GC, German MS, Rutter WJ: The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 9:293-298, 1995
8. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C: Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289-292, 1997
9. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, et al.: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 9:80-85, 1995
10. Owerbach D, Naya FJ, Tsai MJ, Allander SV, Powell DR, Gabbay KH: Analysis of candidate genes for susceptibility to type 1 diabetes: a case-control and family-association study of genes on chromosome 2q31-35. Diabetes 46:1069-1074, 1997
11. Furuta H, Horikawa Y, Iwasaki N, Hara M, Sussel L, Le Beau MM, Davis EM, Ogata M, Iwamoto Y, German MS, Bell GI: β-Cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes 47:1356-1358, 1998
12. Dupont S, Vionnet N, Chevre JC, Gallina S, Dina C, Seino Y, Yamada Y, Froguel P: No evidence of linkage or diabetes-associated mutations in the transcription factors BETA2/NEUROD1 and PAX4 in type II diabetes in France. Diabetologia 42:480-484, 1999
13. Iwata I, Nagafuchi S, Nakashima H, Kondo S, Koga T, Yokogawa Y, Akashi T, Shibuya T, Umeno Y, Okeda T, Shibata S, Kono S, Yasunami M, Ohkubo H, Niho Y: Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 48:416-419, 1999
14. Dupont S, Dina C, Hani EH, Froguel P: Absence of replication in the French population of the association between beta 2/NEUROD-A45T polymorphism and type 1 diabetes. Diabetes Metab 25:516-517, 1999
15. Hansen L, Jensen JN, Urioste S, Petersen HV, Pociot F, Eiberg H, Kristiansen OP, Hansen T, Serup P, Nerup J, Pedersen O: NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes: Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. Diabetes 49:876-878, 2000
16. 45Thr is associated with type 1 diabetes mellitus in Czech children. Diabetes Res Clin Pract 60:49-56, 2003
17. Bain SC, Todd JA, Barnett AH: The British Diabetic Association: Warren repository. Autoimmunity 7:83-85, 1990
18. Lowe CE, Cooper JD, Chapman JM, Barratt BJ, Twells RCJ, Green EA, Savage DA, Guja C, Ionescu-Tirgovişte C, Tuomilehto-Wolf E, Tuomilehto J, Todd JA, Clayton DG: Cost-effective analysis of candidate genes using htSNPs. Genes Immun. In press
19. Lernmark A: Human cell lines from families available for diabetes research (Letter). Diabetologia 34:61, 1991
20. Feltbower RG, McKinney PA, Parslow RC, Stephenson CR, Bodansky HJ: Type 1 diabetes in Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and age-period-cohort modelling. Diabet Med 20:437-441, 2003
21. Patterson CC, Carson DJ, Hadden DR, Waugh NR, Cole SK: A case-control investigation of perinatal risk factors for childhood IDDM in Northern Ireland and Scotland. Diabetes Care 17:376-381, 1994
22. Undlien DE, Akselsen HE, Joner G, Dahl-Jorgensen K, Aagenaes O, Sovik O, Thorsby E, Ronningen KS: No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am J Hum Genet 57:1511-1514, 1995
23. Ionescu-Tirgoviste C, Guja C, Herr M, Cucca E, Welsh K, Bunce M, Marshall S, Todd JA: Low frequency of HLA DRB1*03-DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of type I diabetes. Diabetologia 44 (Suppl. 3):B60-B66, 2001
24. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Akerblom HK: Epidemiology of childhood diabetes mellitus in Finland: background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus: the Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia 35:70-76, 1992
25. Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70:124-141, 2002